Loading clinical trials...

A COPD Data Registry for Participants With Frequent Exacerbations | Clinical Trials | Clareo Health

NOT_YET_RECRUITING

A COPD Data Registry for Participants With Frequent Exacerbations

An Observational, Prospective, Real-world Data Registry in Chronic Obstructive Pulmonary Disease (COPD) Patients Suffering From Frequent Exacerbations (AIREIC)

NCT07059273•Hoffmann-La Roche

View on ClinicalTrials.gov

Summary

This registry will collect data on COPD, including the course of disease, treatment patterns, and potential new therapies. The registry will also track the experience of participants and caregivers in clinical practice.

Eligibility

Age

40 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Diagnosis of COPD for at least 12 months
•On stable, standard of care (SoC) COPD maintenance therapy
•Have experienced at least 2 exacerbations (moderate or severe) in the last 12 months, with one of them occurring while on SoC therapy

Exclusion Criteria

•In palliative treatment
•Participating in any interventional drug trials

Key Dates

Start Date

May 18, 2026

Primary Completion Date

November 18, 2030

Completion Date

November 18, 2030

Last Updated

March 9, 2026

Enrollment

3,000

ESTIMATED participants

Conditions

COPD

Contacts

Reference Study ID Number: BA45495 https://forpatients.roche.com/

CONTACT

888-662-6728 global-roche-genentech-trials@gene.com

cfMSC Stem Cell Therapy Targeting COPD

NCT07477600

Chronic Obstructive Pulmonary Disease (COPD)

View study

RECRUITINGNA

Effect of Telenursing on Oral Health

NCT07462221

COPD

View study

RECRUITINGNA

Emotional-distress-based Integrated Care Programme in Patients With an Acute Exacerbation of COPD

NCT07351929

COPD Exacerbation

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 9, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A COPD Data Registry for Participants With Frequent Exacerbations

Inclusion Criteria

Exclusion Criteria

cfMSC Stem Cell Therapy Targeting COPD

Effect of Telenursing on Oral Health

Emotional-distress-based Integrated Care Programme in Patients With an Acute Exacerbation of COPD

Probiotics in Pulmonaty Rehabilitation for COPD

Effects of Eccentric Exercise Training in Patients With COPD

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3